SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-037330
Filing Date
2020-06-17
Accepted
2020-06-17 17:10:58
Documents
2
Period of Report
2020-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2227
2 POA DOCUMENT poa.txt EX-24.3_922986 4195
  Complete submission text file 0001209191-20-037330.txt   7907
Mailing Address C/O PANACOS PHARMACEUTICALS, INC. 134 COOLIDGE AVENUE WATERTOWN MA 02472
Business Address
Fischer Laurent (Reporting) CIK: 0001379344 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36579 | Film No.: 20970476

Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)